Editas Medicine (EDIT) Tops Q3 EPS by 5c

November 7, 2016 5:12 PM EST
Get Alerts EDIT Hot Sheet
Price: $18.76 --0%

Today's EPS Names:
Trade EDIT Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Editas Medicine (NASDAQ: EDIT) reported Q3 EPS of ($0.59), $0.05 better than the analyst estimate of ($0.64). Revenue for the quarter came in at $962 thousand versus the consensus estimate of $960 thousand.

For earnings history and earnings-related data on Editas Medicine (EDIT) click here.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment